[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 41, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 40, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 51, "title": "Chief People Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.51, "open": 3.52, "dayLow": 3.24, "dayHigh": 3.5274, "regularMarketPreviousClose": 3.51, "regularMarketOpen": 3.52, "regularMarketDayLow": 3.24, "regularMarketDayHigh": 3.5274, "payoutRatio": 0.0, "beta": 0.37, "forwardPE": -1.9817073, "volume": 346859, "regularMarketVolume": 346859, "averageVolume": 1270185, "averageVolume10days": 272740, "averageDailyVolume10Day": 272740, "bid": 3.23, "ask": 3.32, "bidSize": 3, "askSize": 3, "marketCap": 116953528, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 4.689, "fiftyDayAverage": 3.1731, "twoHundredDayAverage": 2.117175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 85170552, "profitMargins": 0.0, "floatShares": 27205191, "sharesOutstanding": 35985700, "sharesShort": 1654759, "sharesShortPriorMonth": 893835, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.046, "heldPercentInsiders": 0.24347, "heldPercentInstitutions": 0.1248, "shortRatio": 0.52, "shortPercentOfFloat": 0.0602, "impliedSharesOutstanding": 35985700, "bookValue": 1.163, "priceToBook": 2.794497, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -61774912, "trailingEps": -1.97, "forwardEps": -1.64, "enterpriseToEbitda": -1.334, "52WeekChange": 2.0789473, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 3.25, "targetHighPrice": 21.0, "targetLowPrice": 3.5, "targetMeanPrice": 11.25, "targetMedianPrice": 11.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 35865696, "totalCashPerShare": 0.997, "ebitda": -63850176, "totalDebt": 4082719, "quickRatio": 7.021, "currentRatio": 7.479, "debtToEquity": 9.757, "returnOnAssets": -0.57901, "returnOnEquity": -1.02475, "freeCashflow": -32395848, "operatingCashflow": -53589096, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 1.23077, "postMarketPrice": 3.29, "postMarketChange": 0.04, "regularMarketChange": -0.26, "regularMarketDayRange": "3.24 - 3.5274", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1270185, "fiftyTwoWeekLowChange": 2.25, "fiftyTwoWeekLowChangePercent": 2.25, "fiftyTwoWeekRange": "1.0 - 4.689", "fiftyTwoWeekHighChange": -1.4390001, "fiftyTwoWeekHighChangePercent": -0.3068885, "fiftyTwoWeekChangePercent": 207.89473, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.97, "epsForward": -1.64, "epsCurrentYear": -1.686, "priceEpsCurrentYear": -1.9276394, "fiftyDayAverageChange": 0.076900005, "fiftyDayAverageChangePercent": 0.024234977, "twoHundredDayAverageChange": 1.1328249, "twoHundredDayAverageChangePercent": 0.53506434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.40741, "regularMarketPrice": 3.25, "corporateActions": [], "postMarketTime": 1754693379, "regularMarketTime": 1754683201, "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]